Where Innovations Meets Personalized and Precision Medicine
Author = Esfahani, Vahidreza
Number of Articles: 3
Covid19 disease and the effect of genetic factors on its severity and weakness

Covid19 disease and the effect of genetic factors on its severity and weakness

Volume 6, Issue 21, Spring 2021, Pages 17-22

https://doi.org/10.22034/pmj.2021.244730

Abbas Ghasemzadeh, Vahidreza Esfahani

Abstract Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), is a severe infection with respiratory and systemic
manifestations. This infectious disease has a complex course and manifests itself with
various clinical presentations, ranging from asymptomatic infection to a severe clinical
course. These variations in severity have raised the question of whether the genetic or
epigenetic variations have a role in COVID-19 susceptibility or severity, and that these
factors can be used to predict the disease course. A whole-genome sequencing performed
on 95 samples of SARS-CoV-2 identified 116 unique mutations, most of which were
missense and synonymous. Moreover, some studies have reported a relationship between
the COVID-19 severity and the genes ACE and TMPRSS2. The present review provides
an overview of different genes that have been found to be implicated or related to the
susceptibility to COVID-19 or its severity.

Detection and Genotyping of HPV Infection Using a New Method Based on Real-Time PCR

Detection and Genotyping of HPV Infection Using a New Method Based on Real-Time PCR

Volume 6, Issue 20, Winter 2021, Pages 15-17

https://doi.org/10.22034/pmj.2021.243879

Abbas Ardalan, Vahidreza Esfahani

Abstract The causalGiven the known relationship between the HPV infection and some malignancies, it is critical to develop methods for quick detection and quantitation of certain HPV types while encountering a suspected lesion. Early HPV detection is greatly important in monitoring and treating the disease development and progression.  Detection of the viral DNA using PCR is the standard, noninvasive method for detecting cervical HPV infection. In the present study, we intended to develop a TaqMan genotyping assay that targets two types of high-risk HPV types (HPV 16 & 18) and two of the low-risk types (6 & 11).
The study included 75 samples positive for HPV, of which 37 were positive for HPV types 16 and 18, while 38 were positive for HPV types 6 and 11. The samples had been confirmed by a reference kit before. The samples underwent real-time PCR. Each reaction consisted of the 1X CAPITAL™ qPCR Probe Master Mix, specific primer pairs for HPV, and fluorescent-tagged probes.
According to our findings, all the samples genotyped using this method were compatible with the results by the reference kit, which was remarkable.
In conclusion, our type-specific approach based on real-time PCR could detect the entire samples positive for four types of HPV.

Investigating the relationship between gene CYP1B1 C4326G polymorphism and the risk of cervical cancer

Investigating the relationship between gene CYP1B1 C4326G polymorphism and the risk of cervical cancer

Volume 5, Issue 19, Autumn 2020, Pages 1-3

https://doi.org/10.22034/pmj.2020.240042

Fadhil Said, Mohammad Al-Tohami, Vahidreza Esfahani

Abstract  
Cervical cancer is a common and deadly cancer among women around the world. One of the genes associated with many cancers is the CYP1B1gene.Some studies have shown that polymorphisms in the CYP1B1 gene can induce hyper activation of proteins and increase the incidence of several cancers. In the present study, we examined the association between the CYP1B1 C4326G polymorphism and the risk of cervical cancer.60 newly diagnosed patients with cervical cancer and 60 cancers-free controls.DNA was extracted by Salting-out method, Restriction fragment length polymorphism PCR was employed to determine the genotype of the CYP1B1 C4326G polymorphisms. the frequencies of the three genotypes (CC, CG, and GG) of CYP1B1 C4326G in cervical cancer cases and controls were 68.0, 25.4, 6.6%and 73.1, 21.4, and 5.5 %, respectively, and there was a significant difference between the two groups (χ2=7.41, P=0.02).  
 


Cervical cancer,CYP1B1, RFLP-PCR, Human papilloma virus